New England Biolabs is delighted to introduce our new sales team who are dedicated to support our valued customers in India. Dr. Anuj Gupta (Business Manager), based in Pune, Dr. Ashwani Kamal (Technical Sales Manager) in Bengaluru, and Dr. Gaurav Garg (Technical Sales Manager) in New Delhi. The NEB India team, along with our national distribution partner Zelle Biotechnology, will bring technical expertise and enhanced service to researchers and entrepreneurs in the dynamic life science sector in India. The team is happy to answer any inquiries through For product related technical support needs please write to

About NEB

Established in the mid 1970s, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics, and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. New England Biolabs is a privately held company, headquartered in Ipswich, MA, USA, and has extensive worldwide distribution through a network of exclusive distributors, agents and eight subsidiaries located in Australia, Canada, China, France, Germany, Japan, Singapore, and the UK. For more information about New England Biolabs visit




One or more of these products are covered by patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc. The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; rather, it indicates where the document was originally developed. For more information, please email us at The use of these products may require you to obtain additional third-party intellectual property rights for certain applications.